Diabetech - Diabetes Tech, Research, News

Eversense 365 is an implantable continuous glucose monitor designed to last for a year, but what is it like to use in everyday life? Certified diabetes care and education specialist Gary Scheiner joins us on the podcast to share his experience after 10 weeks with the sensor, including glucose reading accuracy, calibration requirements, transmitter charging, adhesive options, and on-body vibration alerts. The conversation explores how Eversense 365 compares with disposable CGMs, its use with automated insulin delivery systems, and the challenges of getting through the initial adjustment period. Plus, a look at planned improvements to Eversense and the future of implantable glucose monitoring, including technology designed to measure glucose directly in the bloodstream.

Learn about Omnipod 5 (today's sponsor)*

Learn about the Eversense 365 CGM

Integrated Diabetes - work with Gary's team

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Beta Bionics is bringing its AID technology to a new patch pump format with the FDA-cleared Mint, expected to launch in Q1 2027. Mike Mensinger, Chief Product Officer at Beta Bionics breaks down how Mint’s two-part design works, from its reusable controller, to a Mint site and smartphone app demo. Mensinger shares what’s changing with the iLet, including the upcoming 3D Intelligence algorithm and planned Eversense 365 integration. Lastly, we look ahead at Beta Bionics’ plans for future dual-hormone systems and how the Mint platform could help make those possibilities a reality.

Watch the Mint Post-Show episode

Learn about the Eversense 365 CGM

Learn about Omnipod 5 (sponsor)*

Beta Bionics iLet Real World Data

Watch Next: Bluetooth Underwater | Artificial Pancreas

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

Trio version 1.0 is here! This is the largest system update to date for the open-source automated insulin delivery (AID) system. The latest release adds new pump and CGM integrations, a redesigned app, customizable alerts, glucose forecasts, and new features like Quick Picks. This episode explores how Trio’s open-source approach differs from commercial AID systems and how users can customize the system around their diabetes management needs. Contributors Teresa Hastings and Magnus Wrights also share how they use Trio, including approaches that can reduce the need for manual boluses and carbohydrate entries. The conversation also covers Trio’s algorithm, dynamic insulin sensitivity, Apple Watch and Garmin integration, upcoming pump integrations, and what could be next for open-source AID.

Learn about the Eversense 365 CGM

Learn about Omnipod 5 (sponsor)*

Resources: Triodocs Website  | Loop and Learn  | Hackathon fundraising 

Listen to Diabetes Advocates: YouTube | Apple | Spotify

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. DIY apps are experimental and not approved by the FDA or regulatory authorities at the time of this video. You take full responsibility for building and using DIY apps and you do so at your own risk. Results will vary.

*Omnipod (today's sponsor): 30-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Your pump and CGM lose connection in the pool, and it comes down to centimeters. I sat down with Dr. Michael Hughes, an endocrinologist at Emory University, to break down his research on swimming with automated insulin delivery (AID). His team found the connection held at 100% at 10 cm, dropped to about half at 13 cm, and hit 0% by 17 cm, so where you place your pod and CGM matters a lot for swimming with type 1 diabetes. We also cover what limited mode does when your devices disconnect, and why starting glucose and insulin on board mattered more than connectivity for avoiding lows.

Learn about the Eversense 365 CGM

Learn about Omnipod 5 (sponsor)*

Listen to Diabetes Advocates: YouTube | Apple | Spotify

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

Are you getting the most out of your automated insulin delivery system, or are you still managing it like a traditional insulin pump? Gary Scheiner, CDCES, and I break down 10 ways to optimize your AID system, from fine-tuning pump settings and knowing when to bolus to treating lows and timing insulin more effectively. We also cover how to trust the algorithm, use advanced pump features for exercise and meals, rotate infusion sites, and keep your CGM data reliable.

Learn about Omnipod 5 (today's sponsor)*

Learn about the Eversense 365 CGM

Integrated Diabetes - work with Gary's team

Optimizing Diabetes Tech Playlist

Listen to Diabetes Advocates (New Podcast): Apple | Spotify | YouTube

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Abbott's VP of Technical Operations and Senior Medical Director break down the new Libre Duo sensor, the first continuous glucose ketone monitor. We discuss the growing need for more ketone data, how ketone alerts will appear in the existing Libre app, and why the company designed the experience to minimize alert and information fatigue. The conversation also covers Libre Duo’s compatibility with leading automated insulin delivery systems.

Learn about Omnipod 5 (sponsor)*

Learn about the Eversense 365 CGM

Listen to Diabetes Advocates: YouTube | Apple | Spotify

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

Eledon's CEO, Dr. David-Alexandre Gros, breaks down Tegoprubart, the company’s targeted immunosuppressant being studied alongside islet cell transplants for type 1 diabetes. The conversation covers the promising results seen so far, including insulin independence and improved A1C levels among trial participants, and why Tego could offer a different approach to protecting transplanted cells. The episode also explores what the future of type 1 diabetes treatment could look like as transplantation, stem-cell-derived islets, and new immunosuppressive therapies continue to advance.

Learn about the Eversense 365 CGM

Learn about Omnipod 5 (sponsor)*

Watch Next: Type 1 Diabetes Cure Research 

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Ever wonder what insulin pump options exist outside the U.S.? Dr. Inge Van Boxelaer, a Belgian endocrinologist and founder of Diabetotech, joins us on the podcast and breaks down the European AID system landscape. We cover how MiniMed, Tandem, and Omnipod are performing across European markets, plus a deep dive into European systems like the Kaleido, mylife YpsoPump (with CamAPS FX and the upcoming Liberty algorithm), the Diabeloop-powered systems, and the Medtrum Touchcare. The conversation also explores how reimbursement and regulatory approval vary wildly by country, and where the market is headed next with patch pumps, phone-controlled systems, and fully closed-loop technology.

Learn about Omnipod 5 (sponsor)*

Learn about the Eversense 365 CGM

Check out Diabetotech

Podcast: Medtrum User Interview, CamAPS FX Explained

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Part two of this series continues the conversation about what a cure for type 1 diabetes could actually look like, from cell replacement and immune therapies to insulin innovation and advanced diabetes technology. The discussion explores islet cell transplants, stem cell-derived beta cells, immune suppression, gene-edited cells, and the challenges of making these approaches safer and more widely available. The expert panel also break down why even the most advanced technology today still falls short of a true cure. A major focus is accessibility, including who could benefit from these therapies, how much they might cost, and the infrastructure needed to deliver them to millions of people with type 1 diabetes. The experts discuss their vision for the future of cure research and how far off it could be.

Learn about Omnipod 5 (sponsor)*

Learn about the Eversense 365 CGM

Could Prevention be the Cure for Type 1 Diabetes?

The Cure Post-Show Reaction

Diabetech Feedback Survey

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this episode, I sit down with leading type 1 diabetes researchers and clinicians to break down the science behind prevention, delaying disease progression, and replacing insulin-producing beta cells. We explore promising therapies like teplizumab, ATG, and verapamil, along with the challenges of immunotherapy, beta cell replacement, and making these treatments accessible to more people. This conversation also tackles why we’ve been hearing “a cure in 5 to 10 years” for so long, what researchers have learned about the root causes of type 1 diabetes, and why there’s more progress happening now than ever before.

Learn about Omnipod 5 (sponsor)*

Learn about the Eversense 365 CGM

Inside the Vertex Participant Who's Cured of Type 1 Diabetes - Patti Columbe

The Cure Post-Show Reaction

Join: Diabetech Newsletter (free) | Diabetech All Access

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.